Symptoms and markers of symptom severity in asthma-content validity of the asthma symptom diary

Health and Quality of Life Outcomes

Volumn 13, Issue 1, 2015, Pages

  Globe, Gary ^a   Martin, Mona ^b   Schatz, Michael ^c   Wiklund, Ingela ^d   Lin, Joseph ^a,f   von Maltzahn, Robyn ^d   Mattera, Maria S ^e  

^a AMGEN INC   (United States)

^b Health Research Associates Inc   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d EVIDERA   (United Kingdom)

^e EVIDERA   (United States)

^f GILEAD SCIENCES   (United States)

Author keywords

Asthma; Instrument development; Patient reported outcome; Qualitative; Symptoms

Indexed keywords

ADULT; AGE DISTRIBUTION; ALLERGY; AROUSAL; ARTICLE; ASTHMA; ASTHMA SYMPTOM DIARY; CHEST TIGHTNESS; CLINICAL ASSESSMENT TOOL; CONTENT VALIDITY; COUGHING; DISEASE MARKER; DISEASE SEVERITY; DIZZINESS; DYSPNEA; FATIGUE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; SOCIAL STATUS; SYMPTOMATOLOGY; THROAT DISEASE; WHEEZING; ADOLESCENT; CHEST PAIN; COMORBIDITY; COMPLICATION; COUGH; DAILY LIFE ACTIVITY; HEALTH STATUS INDICATOR; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOMETRY; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP WAKE DISORDERS;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ASTHMA; CHEST PAIN; COMORBIDITY; COUGH; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP WAKE DISORDERS;

EID: 84928662280     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-015-0217-5     Document Type: Article

References (22)

1. American Asthma Foundation. The impact of asthma. http://www.americanasthmafoundation.org/impact-asthma. Accessed 9 July 2013.
2. World Health Organization (WHO). Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. http://www.who.int/gard/publications/GARD%20Book%202007.pdf. Accessed 9 July 2013.
3. Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States. Natl Health Stat Report. 2005;2011:1-14.
4. Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention. 2012. Available from: http://www.ginasthma.org/.
5. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
6. Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, et al. Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol. 2012;129:S65-87.
7. Carranza Rosenzweig JR, Edwards L, Lincourt W, Dorinsky P, ZuWallack RL. The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med. 2004;98:1157-65.
8. Cloutier MM, Schatz M, Castro M, Clark N, Kelly HW, Mangione-Smith R, et al. Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol. 2012;129:S24-33.
9. Zhang J, Yu C, Holgate ST, Reiss TF. Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J. 2002;20:1102-9.
10. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J. 2001;17:220-4.
11. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
12. Boulet LP, Phillips R, O'Byrne P, Becker A. Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J. 2002;9:417-23.
13. Revicki D, Weiss KB. Clinical assessment of asthma symptom control: review of current assessment instruments. J Asthma. 2006;43:481-7.
14. Krishnan JA, Lemanske RF, Canino GJ, Elward KS, Kattan M, Matsui EC, et al. Asthma outcomes: Symptoms. J Allergy Clin Immunol. 2012;129:S124-S35.
15. Food and Drug Administration (FDA). Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009;74:65132-3.
16. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14:967-77.
17. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health. 2011;14:978-88.
18. Global Initiative for Asthma (GINA). GINA Report, Global Strategy for Asthma Management and Prevention. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf. Accessed January 2015.
19. Globe G, Lin S, Schatz M, Mattera MS, Feng JY, Chon Y, et al. Psychometric performance of the Asthma Symptom Diary (ASD) in adult and adolescent subjects with persistent asthma. Miami, Florida, USA: In ISOQOL 20th Annual Conference; 2013.
20. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902-7.
21. Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99:553-8.
22. Busse WW, Morgan WJ, Taggart V, Togias A. Asthma outcomes workshop: overview. J Allergy Clin Immunol. 2012;129:S1-8.